Fundz

Sightera raises €3M to advance its AI-generated molecular glue SIGHT001 for cancer treatment, backed by Entourage Ventures, Anacura, and Qbic Fund.

PRIVATEJul 20, 2026

Amount Raised

€3 Million

Round Type

Seed

BiotechnologyArtificial Intelligence

Investors

Qbic FundAnacuraEntourage Ventures

Description

Sightera has raised €3M to advance its AI-designed molecular glue SIGHT001, targeting KRAS-mutant cancers. This funding round was backed by investors with life sciences expertise, including Entourage Ventures, Anacura, and Qbic Fund. The proceeds will support candidate selection for SIGHT001. The company also continues to develop additional innovative therapies for cancer treatment.

Quick answer

Sightera raised €3 Million in a Seed round, dated July 20, 2026. Investors: Qbic Fund, Anacura and Entourage Ventures.

How much did Sightera raise?
Sightera raised €3 Million in a Seed round on July 20, 2026.
Who invested in Sightera?
Qbic Fund, Anacura and Entourage Ventures are named as investors in this round.
What does Sightera do?
Sightera is an innovative biotechnology company focused on computational drug discovery, utilizing AI-generated molecular glues to enhance drug development.
Where is Sightera based and how big is it?
Fundz records about 2 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as Sightera that raised within 45 days of this round, from Fundz verified event records.

  • DataHow raised an undisclosed amount (Series A) on September 2, 2026.
  • Pharosyn raised $3M (Seed) on September 2, 2026.
  • Intellicia raised $2.8M (Seed) on September 2, 2026.
  • Frontier Computing raised $10M (Pre-Seed) on September 2, 2026.
  • iPremom raised $17M (Seed) on September 2, 2026.
  • ABLE Labs raised $8.7M (Series A) on August 31, 2026.

Who to call at Sightera, and when

A new round usually means Sightera is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sightera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sightera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sightera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sightera

About

Sightera is an innovative biotechnology company focused on computational drug discovery, utilizing AI-generated molecular glues to enhance drug development. The company aims to tackle challenges in translating laboratory predictions into effective medicines by generating its own drug-response data. Sightera is developing several promising therapies, including SIGHT001 for various cancers. It emerged from extensive research at the University of Antwerp and has established itself as an academic spin-off.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sightera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Sightera's next move

See what Strategic adds

Sightera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.